L
Lianchuang Biosciences
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2021 | $14M | $55M | Addor Capital · Yida Capital | — |
Growth signals
Latest recorded traffic for Lianchuang Biosciences is 1K monthly website visits, down 72.2% over the last three months. Lianchuang Biosciences's team declined 16.7% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Lianchuang Biosciences in the Huainan City ecosystem
The Lianchuang Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Addor Capital
- YCYida Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lianchuang Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lianchuang Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.